688607 CareRay Digital Medical Technology
- 12.89
- -0.44-3.30%
CareRay Digital Medical Technology News
Kangzhong Medical (688607.SH) announced first-quarter results with net profit of 1.168,800 yuan
Kangzhong Medical (688607.SH) released its report for the first quarter of 2024. During the reporting period, the company achieved an operating income of 5...
?? Zhong Medical (688607): Market demand is gradually resuming and the incentive plan is optimistic about subsequent development
Incident: The company released its 2023 annual report: The company achieved operating income of 274 million yuan (+34% year over year) and net profit of 15.41 million yuan (year-on-year reversal of loss to profit). Comment: Market demand is gradually recovering, and new products are steady
Kangzhong Medical (688607): New product release+demand recovery, domestic market growth of 48%
Incident: The company released its 2023 annual report, achieved operating income of 274 million yuan (yoy +34%) in 2023, achieved net profit of 15.41 million yuan, deducted net profit not returned to mother of 970,000 yuan, generated from operating activities
Kangzhong Healthcare (688607.SH): Plans to launch a 780,000 restricted stock incentive plan
Gelonghui, April 19 | Kangzhong Healthcare (688607.SH) announced the 2024 restricted stock incentive plan. This incentive plan grants a total of 7800 million restricted shares, accounting for 0.89% of the company's total share capital when this incentive plan was announced. Among them, 75,000 shares were granted for the first time, accounting for 0.85% of the company's total share capital when the incentive plan was announced, accounting for 96.15% of the total amount of restricted shares granted under the incentive plan; 30 million shares were reserved, accounting for 0.03% of the company's total share capital when the incentive plan was announced, and 3.85% of the total restricted stock granted under the incentive plan.
Kangzhong Healthcare (688607.SH): Net profit of 154.12,200 yuan in 2023 turned a year-on-year loss into a profit
Gelonghui, April 19 | Kangzhong Healthcare (688607.SH) released its 2023 annual report. During the reporting period, it achieved operating income of 274 million yuan, an increase of 33.81% over the previous year; net profit to mother was 154.12,200 yuan, turning a year-on-year loss into a profit; deducting 968,200 yuan in non-net profit; and basic earnings per share of 0.17 yuan. The company plans to distribute a cash dividend of RMB 0.54 (tax included) for every 10 shares to all shareholders.
CareRay Digital Medical Technology Buys Back 10 Million Yuan Worth of Shares; Shares Up 9%
CareRay Digital Medical Technology (SHA:688607) repurchased shares for nearly 10 million yuan, according to the company's dislcosure on the Shanghai Stock Exchange. The Chinese digital radiography ser
Kangzhong Medical (688607.SH): cumulative repurchase of 0.8371% of shares
Gelonghui, April 16, 丨 Kangzhong Medical (688607.SH) announced that as of April 15, 2024, the company had repurchased a total of 737,722 shares of the company through centralized bidding transactions, accounting for 0.8371% of the company's total share capital. The highest price of the repurchase transaction was 14.49 yuan/share, the lowest price was 12.64 yuan/share, and the total capital paid was RMB 9,997,724.29 (excluding transaction fees such as stamp duty and transaction fees).
Market Might Still Lack Some Conviction On CareRay Digital Medical Technology Co., Ltd. (SHSE:688607) Even After 31% Share Price Boost
Those holding CareRay Digital Medical Technology Co., Ltd. (SHSE:688607) shares would be relieved that the share price has rebounded 31% in the last thirty days, but it needs to keep going to repair t
Express News | More than 30 listed companies disclosed repurchase plans after the market and announced that 4 listed companies including Liangwei plan to repurchase for cancellation
Express News | Kangzhong Medical: Plans to repurchase shares for 8 million yuan to 12 million yuan
Kangzhong Medical (688607.SH) performance report: 2023 net profit of 15.605 million yuan
Gelonghui, Feb. 23: Kangzhong Medical (688607.SH) announced the 2023 Annual Results Report. During the reporting period, the company achieved total revenue of 27,3012,200 yuan, an increase of 33.46% over the same period last year. The main reason is that the company is comprehensively promoting the steady growth of operating income by accelerating the application transformation and marketing of new products and technologies, continuously improving the competitiveness and product richness of the company's products, and strengthening the expansion of new customers. During the reporting period, the company achieved operating profit of 14.2388 million yuan, an increase of 24.44,800 yuan over the same period last year; realized profit
Market Cool On CareRay Digital Medical Technology Co., Ltd.'s (SHSE:688607) Revenues Pushing Shares 26% Lower
The CareRay Digital Medical Technology Co., Ltd. (SHSE:688607) share price has fared very poorly over the last month, falling by a substantial 26%. The drop over the last 30 days has capped off a t
Kangzhong Medical (688607.SH): Net profit pre-profit of 13.75 million yuan to 18 million yuan in 2023
Gelonghui, January 29丨Kangzhong Medical (688607.SH) announced its 2023 annual results forecast. According to preliminary estimates by the finance department, the company is expected to achieve net profit of 13.75 million yuan to 18 million yuan in 2023, which is an increase of 19.3739 million yuan to 23.6239 million yuan compared with the same period last year of -5.6239 million yuan (statutory disclosure data). The company is expected to achieve net profit of -10.36,500 yuan to 3,213,500 yuan after deducting non-recurring profit and loss attributable to the owner of the parent company in 2023
Kangzhong Medical (688607.SH): 21.62 million restricted shares will be listed and circulated on February 1
Gelonghui, January 24, 丨 Kangzhong Medical (688607.SH) announced that the total number of shares in circulation that have been lifted and applied for listing is 21.62 million shares. The sales restrictions are all 36 months from the date the company's shares are listed. The current sales restriction period is about to expire and will be listed and circulated from February 1, 2024 (Thursday).
Kangzhong Medical (688607.SH) plans to acquire 30% of ISDI's shares and will introduce ISDI's CMOS product line in China
Kangzhong Medical (688607.SH) issued an announcement. The company plans to use its own operating capital of 12 million pounds to pass through all...
Kangzhong Medical (688607.SH): Changcheng and Junlian Chengyu reduced their holdings by 592,400 shares, and their holdings ended
Gelonghui November 10 | Kangzhong Medical (688607.SH) announced that as of the expiration date of this holdings reduction plan (since November 11, 2023 is a non-trading day, it was brought forward to November 10, 2023), Changcheng and Junlian Chengyu have reduced their holdings of the company by a total of 592,400 shares through centralized bidding, accounting for 0.67% of the company's total share capital.
Kangzhong Medical (688607.SH): Changcheng and Junlian Chengyu reduced their shares by 1.06% by a total of 1.06%
Gelonghui November 3 | Kangzhong Medical (688607.SH) announced that during this equity change, Changcheng and Junlian Chengyu reduced their holdings of the company by a total of 933,157 shares through bulk transactions and centralized bidding, accounting for 1.06% of the company's total share capital. After this change in equity, Changcheng and Junlian Chengyu held a total of 11,353,121 shares of the company, with a share ratio of 12.88%.
[BT Financial Report Instantaneous Analysis] Kangzhong Medical's 2023 Three-Quarter Report: Operating income increased by 26.62%, net profit turned loss into profit
This financial report was announced at 22:23:45 2023-10-27. Kangzhong Medical (stock code: 688607) is an enterprise focusing on the production of key components of digital X-ray imaging systems. Its main products are digital X-ray flat panel detectors, which are used in the category of X-ray imaging equipment in medical imaging equipment. The company's industry is specialized equipment manufacturing, particularly medical imaging equipment and services in the biomedical engineering industry. In terms of assets and liabilities, at the end of the third quarter of 2023, Kangzhong Medical's total assets were 931 million yuan, up from 903 million yuan at the end of the previous year
Kangzhong Medical (688607.SH): Achieved net profit of 4.4088 million yuan in the third quarter
On October 27, Gelonghui (688607.SH) announced that in the third quarter of 2023, Kangzhong Medical () announced that in the third quarter of 2023, it achieved operating income of 704666 million yuan, an increase of 65.52% over the previous year; net profit attributable to shareholders of listed companies was 4,4088 million yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 1,006 million yuan, with basic earnings per share of 0.05 yuan.
Kangzhong Healthcare (688607.SH) released the first half of the year results, with a net loss of 111.1 million yuan, narrowing the year-on-year loss
Kangzhong Medical (688607.SH) released the 2023 semi-annual report. During the reporting period, the company achieved operating income...
Analysis
Price Target
No Data
